Table 2.

Effect of BM-MSCs and/or IMC on lipid peroxides and antioxidant status of CFA-induced arthritic rats.

Parameters
Groups	MDA (nmole/L) × 10	% change	GSH (nmole/L) × 102	% change	SOD (U/L) × 10	% change	GPx (U/L)	% change	GST (U/L) × 102	% change
Normal	1.8 ± 0.6d	—	43.74 ± 0.94a	—	15.5 ± 1.6a	—	87.00 ± 3.06a	—	9.35 ± 1.19a	—
CFA	19.1 ± 3.6a	961.11	35.1 ± 1.97b	−19.75	7.1 ± 0.9b	−54.19	36.17 ± 7.39c	−58	6.11 ± 0.42b	−34.71
CFA + BM-MSCS	7.4 ± 0.5bc	−61.26	42.07 ± 1.17a	19.86	10.6 ± 0.7ab	49.30	61.00 ± 3.87b	69	7.97 ± 0.15ab	30.45
CFA + IMC	10.2 ± 1.9b	−46.60	37.27 ± 0.96b	6.18	11.7 ± 1.2ab	64.79	60.00 ± 5.29b	66	7.64 ± 0.82ab	25.11
CFA + BM-MSCs + IMC	5.2 ± 0.6cd	−72.77	43.22 ± 1.75a	23.13	15.1 ± 2.5a	112.68	80.00 ± 5.51ab	121	10.18 ± 1.15a	66.74

(i) Data are described as mean ± standard error. Number of samples in each group is eight. (ii) For each parameter, means, which have different superscript symbols, are significantly different atP  < 0.05. (iii) Percentage (%) changes were calculated by comparing the CFA-arthritic control group with normal and comparing the arthritic-treated groups with the CFA-arthritic group.